Our Pricing

How to Use Your Mounjaro Discount Code UK

Published on: June 03, 2026

Searching for a verified mounjaro discount code uk? At Cured Pharmacy, new patients can access Mounjaro (tirzepatide) from £124.99 using code WEIGHTLOSSNEW — with transparent pricing shown before your free clinical consultation. Our UK-registered prescribers assess your suitability within minutes, and all treatments are dispensed by our GPhC-registered pharmacy team.

Understanding Mounjaro Pricing in the UK

Mounjaro (tirzepatide) represents the latest advancement in weight management medication, licensed by the MHRA for adults with a BMI of 30 or above, or 27 with weight-related health conditions [1]. As a prescription-only medication, pricing varies across UK pharmacies depending on dose strength and supply duration.

At Cured Pharmacy, we guarantee the lowest UK pricing with full transparency — you'll see exact costs before completing your consultation. Our pricing structure starts from £135.00, with no hidden consultation fees or administrative charges. Every prescription includes free assessment by our UK clinical team, discreet packaging, and tracked delivery.

The cost reflects genuine UK-licensed Mounjaro KwikPens manufactured by Eli Lilly, not compounded alternatives. Each pen contains pre-measured doses designed for once-weekly subcutaneous injection, with dosing schedules determined by your prescriber based on clinical response and tolerability.

How Mounjaro Works: Dual-Receptor Mechanism

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management [1]. This dual-action mechanism distinguishes it from single-pathway treatments, activating two complementary hormone systems that regulate appetite, food intake, and energy metabolism.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly exceeding results from single-receptor medications [2]. The dual mechanism appears to produce more substantial effects on satiety signalling and energy expenditure than GLP-1 activation alone.

Clinical data demonstrates that tirzepatide delays gastric emptying, reduces appetite between meals, and improves glycaemic control in patients with type 2 diabetes [1]. These effects combine to support sustainable weight reduction when used alongside dietary modification and increased physical activity, as assessed and recommended by your UK prescriber.

Expected Timeline and Results

Most patients begin noticing appetite reduction within the first 1-2 weeks of treatment, though measurable weight loss typically becomes evident after 4-6 weeks [2]. Your prescriber will initiate treatment at a lower dose (2.5mg weekly) and gradually increase over 16-20 weeks to minimise gastrointestinal side effects whilst optimising therapeutic response.

Clinical trials show the greatest weight reduction occurs between weeks 20 and 72, with patients maintaining reduced body weight throughout the maintenance phase when treatment continues [2]. Individual results vary based on baseline BMI, adherence to lifestyle modifications, and metabolic factors — your UK prescriber will monitor progress and adjust dosing accordingly.

Mounjaro vs Wegovy: Clinical Comparison

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are injectable medications licensed by the MHRA for weight management, but they differ in receptor activity and clinical outcomes. Wegovy activates only GLP-1 receptors, whilst Mounjaro provides dual GIP/GLP-1 agonism, potentially explaining the enhanced weight reduction observed in head-to-head comparisons.

The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg in patients with type 2 diabetes, demonstrating superior weight loss across all tirzepatide dose levels [3]. Participants on tirzepatide 15mg lost an average of 13.1kg compared to 7.9kg with semaglutide over 40 weeks, representing a clinically meaningful difference.

Both medications require once-weekly subcutaneous injection and share similar side effect profiles, predominantly gastrointestinal symptoms during dose escalation. Your UK prescriber will recommend the most appropriate option based on your medical history, previous treatment responses, and individual risk factors. Neither medication guarantees specific outcomes, and both require ongoing lifestyle modification for optimal results.

Choosing Between Treatment Options

Selection between Mounjaro and alternative weight management medications depends on multiple clinical factors assessed during your consultation. Patients with type 2 diabetes may particularly benefit from tirzepatide's superior glycaemic control, whilst those with cardiovascular risk factors might be guided toward medications with established cardiovascular outcome data [3].

Cost considerations also influence treatment selection. Whilst Mounjaro pricing reflects its advanced dual-mechanism formulation, other effective options exist at different price points. Your prescriber will discuss all suitable alternatives, ensuring you understand comparative benefits, limitations, and costs before making an informed decision.

Applying Your Mounjaro Discount Code UK

New patients at Cured Pharmacy can access preferential pricing using discount code WEIGHTLOSSNEW during the checkout process. This offer applies to first-time orders and combines with our lowest-price guarantee, ensuring you receive the most competitive rate available from any UK-registered pharmacy.

To redeem your mounjaro discount code uk, complete the free online consultation with our UK prescribers — the assessment takes under 3 minutes and covers your medical history, current medications, and weight management goals. If Mounjaro is deemed clinically appropriate, you'll proceed to checkout where the discount code field appears before payment.

Enter WEIGHTLOSSNEW in the promotional code box and the discount applies automatically to your order total. Your final price reflects the reduced rate, with no additional consultation fees or hidden charges. All orders include tracked delivery, and our pharmacy team contacts you if any questions arise before dispensing your prescription.

Eligibility and Terms

The discount code applies exclusively to new patients ordering Mounjaro for the first time through Cured Pharmacy. It cannot be combined with other promotional offers or applied retrospectively to previous orders. Clinical approval by our UK prescribers remains mandatory — the discount does not guarantee prescription approval, which depends entirely on your individual medical suitability.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all prescribing decisions to ensure patient safety and regulatory compliance. If Mounjaro is not suitable for you, our prescribers will discuss alternative weight management options available through our service, some of which may be more appropriate for your clinical profile.

Starting Treatment: What to Expect

After clinical approval, your first Mounjaro prescription arrives in discreet packaging with full patient information leaflets and injection guidance. The KwikPen device comes pre-filled and pre-measured, requiring only attachment of a sterile needle (supplied separately) before subcutaneous injection into your abdomen, thigh, or upper arm.

Your prescriber will specify your starting dose — typically 2.5mg once weekly for the first four weeks. This gradual initiation minimises common gastrointestinal side effects such as nausea, which affects approximately 20-30% of patients during dose escalation but generally improves with continued use [1]. Taking the injection on the same day each week, with or without food, optimises consistency and treatment response.

Most patients escalate to higher doses every 4 weeks based on tolerability and weight loss progress, eventually reaching a maintenance dose between 10mg and 15mg weekly. Your UK prescriber will monitor your response through follow-up consultations, adjusting the treatment plan if side effects become problematic or weight loss plateaus. Never adjust your dose without prescriber guidance, as this may increase adverse effects or compromise efficacy.

Safety Considerations and Contraindications

Mounjaro is not suitable for everyone. Absolute contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and known hypersensitivity to tirzepatide or excipients [4]. Your UK prescriber will screen for these conditions during your consultation, along with assessing kidney function, history of pancreatitis, and diabetic retinopathy status.

Common side effects reported in clinical trials include nausea (affecting up to 30% of patients), diarrhoea, vomiting, constipation, and injection site reactions [1]. These typically diminish after the first 8-12 weeks as your body adjusts to treatment. More serious but rare adverse effects include acute pancreatitis, gallbladder disease, and severe hypoglycaemia when used with insulin or sulfonylureas — your prescriber will review all current medications to minimise interaction risks.

Pregnant or breastfeeding women should not use Mounjaro, and effective contraception is recommended for women of childbearing potential, discontinuing treatment at least 2 months before planned conception [4]. If you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction whilst taking Mounjaro, stop injections immediately and contact your prescriber or seek emergency medical attention.

Our clinical team at Cured Pharmacy maintains ongoing monitoring protocols for all patients on weight management medications. You'll receive follow-up contact to assess treatment response, tolerability, and any concerns. This pharmaceutical care model, overseen by our superintendent pharmacist, ensures safe prescribing aligned with MHRA guidance and NICE recommendations for obesity management.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/14617 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to lifestyle modifications. Mounjaro is not suitable for everyone — your prescriber will assess your medical suitability during consultation.